Acute Pain Management in Peritoneal Dialysis Patients

First-Line Options for Mild to Moderate Pain

• The American Journal of Kidney Diseases recommends acetaminophen as the first-line analgesic for mild pain in peritoneal dialysis patients, with dose adjustment to 300-600 mg every 8-12 hours 3, 4
• The American Journal of Kidney Diseases advises avoiding NSAIDs and COX-2 inhibitors as they may be particularly harmful to residual kidney function in dialysis patients 5, 3

Opioid Selection for Moderate to Severe Pain

• The Annals of Oncology suggests fentanyl (transdermal or intravenous) as the safest opioid for patients with severe renal impairment, including those on peritoneal dialysis 1, 2, 6
• The Annals of Oncology recommends buprenorphine (transdermal or intravenous) due to its favorable pharmacokinetic profile in renal impairment 6

Administration Guidelines

• The Annals of Oncology advocates for the oral route as the first choice when possible 1, 2
• The Annals of Oncology states that intravenous opioids have a shorter onset of analgesic activity for severe pain requiring rapid relief 2
• The Annals of Oncology recommends using all opioids with caution and at reduced doses and frequency in renal impairment 1, 2

Special Considerations

• The American College of Cardiology recommends transfer by EMS to an acute care setting if pain is unremitting during dialysis sessions 7, 8
• The Kidney International suggests considering non-pharmacological approaches such as cognitive behavioral therapy, physical activity, and meditation as adjuncts to pharmacological management 9

Dosing Adjustments

• The Annals of Oncology recommends individual titration of dosages using immediate-release formulations before transitioning to long-acting preparations 1, 6
• The Annals of Oncology suggests rescue doses for breakthrough pain should be approximately 10-15% of the total daily dose 6

Common Pitfalls to Avoid

• The American Journal of Kidney Diseases warns against using NSAIDs for pain control, which can accelerate loss of residual kidney function 5, 3
• The Annals of Oncology advises against prescribing full doses of opioids without accounting for reduced clearance in renal impairment 1
• The Annals of Oncology emphasizes the importance of regular pain assessment and dose adjustment based on response and side effects 1, 2